| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 04/26/1995 | EP0649855A1 Use of nucleosides and nucleoside derivatives with enzymatically cleavable protecting groupes in the synthesis of oligonucleotiden |
| 04/26/1995 | EP0649847A2 Process and intermediates for the preparation of (+)- hydantocidin and analogs thereof |
| 04/26/1995 | EP0649429A1 Heteroatomic oligonucleoside linkages |
| 04/26/1995 | EP0649411A1 Boronated compounds |
| 04/26/1995 | CN1028295C Preparation method of deoxynucleoglucoside-3-cyanethyl-N,N-disopropyl phosphorite amide |
| 04/25/1995 | US5410068 Succinimidyl trityl compounds and a process for preparing same |
| 04/25/1995 | US5410045 Rubyrin and related expanded porphyrins |
| 04/25/1995 | US5410033 Converting diol groups of nuclosides to mesylate or tosylate groups, reacting with alkali or alkaline telluride or selenide to produce desired olefinic unsaturation at 2',3'position in sugar moiety of nucleosides |
| 04/25/1995 | US5409906 α nucleoside compounds and a method for treating HBV using said compounds |
| 04/25/1995 | CA1335368C Macrolide compounds and their preparation |
| 04/25/1995 | CA1335356C Therapeutic uses of 2',5'-oligoadenylates |
| 04/22/1995 | CA2118469A1 Process and intermediates for the preparation of (+)- hydantocidin and analogs thereof |
| 04/21/1995 | CA2118153A1 Use of nucleosides and nucleoside derivatives provided with enzymatically cleavable protecting groups in the synthesis of oligonucleotides |
| 04/20/1995 | WO1995010287A1 Substituted purine nucleoside analogs and method for treating endotoxin shock |
| 04/19/1995 | EP0648220A1 Deuterated nucleosides |
| 04/19/1995 | EP0648218A1 Therapeutic nucleosides |
| 04/19/1995 | EP0517796B1 Oligonucleotide analogs |
| 04/13/1995 | WO1995009863A1 Process and antiparasitic intermediates for doramectin |
| 04/13/1995 | WO1995007718A3 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 04/12/1995 | EP0647849A2 Detecting the presence of analytes in a sample |
| 04/12/1995 | EP0647654A2 Anomeric flouroribosyl amines |
| 04/12/1995 | CN1101350A Nucleoside derivatives and anti-herpes composition |
| 04/11/1995 | US5405950 N4 -substituted cytidines and process for incorporation into an oligonucleotides |
| 04/11/1995 | US5405867 Milbemycin derivatives with insecticidal and anthelmintic properties; for plants and animals |
| 04/11/1995 | US5405783 Removing photoremovable protective group from region of substrate, contacting with protected amino acid, repeating to form peptide |
| 04/11/1995 | US5405753 Reacting cytidine-5'-monophosphate with a neuraminic acid compound; then labeling with a fluorescent compound |
| 04/11/1995 | CA1335201C S-adenosyl methionine inhibitors |
| 04/11/1995 | CA1335187C Dideoxyinosine by enzymatic deamination of dideoxyadenosine |
| 04/06/1995 | WO1995009244A1 Method of preparing arabinonucleotides |
| 04/06/1995 | WO1995009175A1 Ring-expanded nucleosides and nucleotides |
| 04/06/1995 | DE4333571A1 Immunoassays for azadirachtines |
| 04/06/1995 | CA2172817A1 Method of preparing arabinonucleotides |
| 04/05/1995 | EP0646125A1 1,5-anhydrohexitol nucleoside analogues and pharmaceutical use thereof |
| 04/05/1995 | CN1028106C Therapeutic nucleosides |
| 04/04/1995 | US5403738 Microorganism for producing polycyclic ether antibiotics |
| 04/04/1995 | US5403726 Enzymatic process for producing a galactosylβ1,3glycal disaccaride using β-galactosidase |
| 03/30/1995 | WO1995008541A1 Conformationally locked nucleoside analogues |
| 03/29/1995 | EP0346427B1 Macrocyclic compounds |
| 03/29/1995 | CN1100728A Nucleosides and oligonucleotides having 2'-ether groups |
| 03/28/1995 | US5401838 Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides |
| 03/28/1995 | US5401726 2'methylidenepyrimidine nucleoside compounds, their use and method for production thereof |
| 03/28/1995 | US5401725 Treatment of tumors, rheumatoid arthritis and other diseases caused by vascular hyperplasia |
| 03/28/1995 | US5401724 Therapeutic treatment of chronic myelogenous leukemia by administration of 2-chloro-2'-deoxy adenosine |
| 03/28/1995 | US5401490 Markers of tissue hypoxia |
| 03/23/1995 | WO1995007921A1 Chemical compounds, their preparation and use |
| 03/23/1995 | WO1995007920A1 Nucleotide analogs |
| 03/23/1995 | WO1995007919A1 Method for dosing therapeutic compounds |
| 03/23/1995 | WO1995007918A2 Pyrimidine derivatives for labeled binding partners |
| 03/23/1995 | WO1995007917A1 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents |
| 03/23/1995 | WO1995007718A2 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 03/23/1995 | CA2171940A1 Chemical compounds, their preparation and use |
| 03/23/1995 | CA2171868A1 Method for dosing therapeutic compounds |
| 03/22/1995 | EP0644196A1 TTTr as a protecting group in nucleotide synthesis |
| 03/22/1995 | EP0643970A2 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide for use in medical treatment of humans |
| 03/22/1995 | EP0643720A1 Binding competent oligomers containing 2', 5' linkages |
| 03/22/1995 | EP0643718A1 IMMUNOSUPPRESSIVE AND TOLEROGENIC MODIFIED LEWIS?C AND LacNAc COMPOUNDS |
| 03/22/1995 | CN1100303A L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents |
| 03/21/1995 | US5399717 Glycosidation route to 4"-epi-methylamino-4"-deoxyavermectin B1 |
| 03/21/1995 | US5399682 Process for preparing 2,3'-O-cyclocytidine |
| 03/21/1995 | US5399681 Alkylation with ethyleneimine, rearrangement, bonding to polymer or macromolecule solid support |
| 03/21/1995 | US5399675 Acidic polycyclic ether antibiotics and microorganisms useful in the production thereof |
| 03/21/1995 | US5399590 Treatment of skin tumors, rheumatic diseases |
| 03/21/1995 | CA1334846C Lipid derivatives of antiviral nucleosides, liposomal incorporation and method of use |
| 03/18/1995 | CA2132133A1 Tttr as protective group in nucleotide synthesis |
| 03/16/1995 | WO1995007364A1 Nucleic acid ligands and improved methods for producing the same |
| 03/16/1995 | WO1995007288A1 Antiretroviral substance prohibicin and microorganism producing the same |
| 03/16/1995 | WO1995007287A1 2' OR 3'-DEOXY AND 2'-DIDEOXY-β-L-PENTAFURANONUCLEOSIDE COMPOUNDS, METHOD OF PREPARATION AND APPLICATION IN THERARY, ESPECIALLY AS ANTI-VIRAL AGENTS |
| 03/16/1995 | WO1995007086A1 Nucleosides with anti-hepatitis b virus activity |
| 03/16/1995 | WO1994024144A3 Enhanced triple-helix and double-helix formation with oligomers containing modified purines |
| 03/16/1995 | CA2169536A1 Nucleic acid ligands and improved methods for producing the same |
| 03/15/1995 | EP0643069A1 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof |
| 03/15/1995 | EP0642589A1 Method and reagent for inhibiting viral replication |
| 03/15/1995 | EP0642527A1 Amphiphilic nucleoside phosphate analogs. |
| 03/15/1995 | EP0642526A1 Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of gdp-fucose |
| 03/15/1995 | EP0642516A1 Macrocyclic immunomodulators |
| 03/15/1995 | EP0642347A1 Use of 2-halo adenine derivatives as therapeutic agents against chronic myelogenous leukemia |
| 03/15/1995 | CN1027896C Antiviral, highly water soluble, stable, crystalline salts of 2'-3'-dideoxyinosine monohydrate, 2'3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-Fluoroinosine hemihydrate |
| 03/14/1995 | US5397571 Co-extraction of azadirachtin and neem oil |
| 03/09/1995 | WO1995006731A2 Non-nucleotide containing enzymatic nucleic acid |
| 03/09/1995 | WO1995006659A1 Amine-derivatized nucleosides and oligonucleosides |
| 03/09/1995 | WO1995006474A1 Thiol-derivatized nucleosides and oligonucleosides |
| 03/09/1995 | CA2169645A1 Non-nucleotide containing enzymatic nucleic acid |
| 03/08/1995 | EP0641352A1 4-ethoxy 5-fluoro 2'deoxyuridine. |
| 03/08/1995 | EP0641327A1 Novel alpha-mannosidase inhibitors |
| 03/08/1995 | EP0521923B1 Process for producing nucleosides, and analogs therof |
| 03/08/1995 | CN1099756A Tetrahydropyran derivatives |
| 03/01/1995 | EP0640614A2 Stereoselective process for preparing beta-anomer enriched 2-deoxy-2, 2-difluoro-d-ribofuranosyl-3, 5-hydroxy protected-1-alkyl and aryl sulfonate intermediates |
| 03/01/1995 | EP0640092A1 A process for the preparation of ribonucleotide reductase inhibitors. |
| 03/01/1995 | EP0640091A1 Synthesis of nucleotide monomers |
| 03/01/1995 | CN1099394A Antiparasitic agents |
| 02/28/1995 | US5393878 Pyrimidine nucleosides having cyclopentafuran skeleton |
| 02/28/1995 | US5393744 Glucosyl phosphotriesters of thymidine |
| 02/28/1995 | US5393615 Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof |
| 02/23/1995 | WO1995005391A1 Applications of fluorescent n-nucleosides and fluorescent structural analogs of n-nucleosides |
| 02/23/1995 | WO1995005390A1 THERMODYNAMICALLY STABLE CRYSTAL FORM OF 4'-DEOXY-4'-EPI-METHYLAMINO AVERMECTIN B1a/B1b BENZOIC ACID SALT AND PROCESSES FOR ITS PREPARATION |
| 02/23/1995 | CA2145750A1 Applications of fluorescent n-nucleosides and fluorescent structural analogs of n-nucleosides |
| 02/22/1995 | EP0639582A2 Polynucleotide assay reagent and method |
| 02/21/1995 | US5391739 Adenosine antagonists |
| 02/16/1995 | WO1995004747A1 Infra-red dye-labelled nucleotides and their use in nucleic acid detection |
| 02/16/1995 | WO1995004746A1 Antiparasitic agents |